Riyadh, Saudi Arabia – 8 March 2026: SMC Healthcare has reported robust financial results for the fourth quarter and full year of 2025, highlighting strong revenue growth, improved operational performance, and continued expansion across its healthcare network.
The company’s board of directors recommended a cash dividend of SAR 80 million for the 2025 fiscal year, equivalent to SAR 0.32 per share, reflecting its solid financial position and commitment to delivering sustainable returns to shareholders. 20260308_SMC – Q4 2025 Earnings…
For the full year, SMC Healthcare recorded revenue of SAR 1.54 billion, representing a 7% year-on-year increase, supported by strong demand for acute healthcare services and the expansion of outpatient clinics. Net profit reached SAR 266.2 million, marking a 43.7% increase compared to 2024, while EBITDA rose 25% to SAR 416.5 million, driven by operational improvements and higher service utilization. 20260308_SMC – Q4 2025 Earnings…
The fourth quarter delivered particularly strong performance, with revenue reaching SAR 406.9 million, up 24.4% year-on-year. Net profit surged to SAR 134 million, reflecting both operational growth and a one-time gain from the sale of land linked to the Al-Wadi Real Estate Fund. 20260308_SMC – Q4 2025 Earnings…
Operationally, the company continued executing its strategy to expand higher-margin healthcare services and strengthen its outpatient network. During 2025, SMC Healthcare opened 57 outpatient clinics, helping drive total outpatient visits to approximately 1.4 million during the year. 20260308_SMC – Q4 2025 Earnings…
Looking ahead, SMC Healthcare plans to continue expanding its footprint through new hospitals and outpatient facilities in Riyadh, aligning its growth strategy with Saudi Arabia’s Vision 2030 healthcare transformation goals.
